TARDBP has been previously explored as a direct substrate of HDAC6: acetylated TARDBP aggregates are found in patients with amyotrophic lateral sclerosis (ALS)63 and deacetylation of TARDBP by HDAC6 prevents TARDBP aggregation63. This evidence concerns the gene HDAC6 and amyotrophic lateral sclerosis.